Company Valuation: Alterity Therapeutics Limited

Data adjusted to current consolidation scope
Fiscal Period: June 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 43.75 21.56 11.37 14 59.84 85.18 - -
Change - -50.72% -47.27% 23.14% 327.48% 42.34% - -
Enterprise Value (EV) 1 43.75 21.56 11.37 9.172 38.2 39.99 44.3 48.07
Change - -50.72% -47.27% -19.31% 316.5% 4.68% 10.77% 8.53%
P/E - - - - - -0.33x -0.33x -0.33x
PBR - - - - - - - -
PEG - - - - - - -0.56x -1.7x
Capitalization / Revenue 13.3x 6.11x 4.45x 4.81x 11.3x 33.2x 71x 35.7x
EV / Revenue 13.3x 6.11x 4.45x 3.15x 7.24x 15.6x 36.9x 20.2x
EV / EBITDA - - - -0.71x -4.68x -2.56x -1.95x -2.07x
EV / EBIT -4.07x -2.07x -1.22x -0.71x -4.87x -2.38x -1.4x -1.35x
EV / FCF - -2.53x - -1.07x -5.11x -3.83x -2.04x -2.25x
FCF Yield - -39.6% - -93.4% -19.6% -26.1% -49.1% -44.5%
Dividend per Share 3 - - - - - - - -
Rate of return - - - - - - - -
EPS 3 - - - - - -1.707 -1.717 -1.72
Distribution rate - - - - - - - -
Net sales 1 3.292 3.528 2.554 2.909 5.278 2.568 1.2 2.383
EBITDA 1 - - - -12.95 -8.155 -15.64 -22.74 -23.26
EBIT 1 -10.75 -10.42 -9.321 -12.97 -7.839 -16.81 -31.6 -35.56
Net income 1 -11.19 -8.843 -8.966 -12.97 -7.927 -14.64 -29.66 -33.25
Net Debt 1 - - - -4.826 -21.64 -45.19 -40.88 -37.1
Reference price 3 1.4000 0.6500 0.3500 0.2000 0.5000 0.5600 0.5600 0.5600
Nbr of stocks (in thousands) 41,680 48,137 48,798 104,902 182,547 217,508 - -
Announcement Date 8/31/21 8/31/22 8/31/23 8/29/24 8/28/25 - - -
1AUD in Million2USD in Million3AUD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
-0.33x15.57x-2.56x - 85.18M
32.24x5.76x17.3x1.02% 46.86B
-23.62x354.58x-21.66x-.--% 40.23B
48.91x4.94x31.87x-.--% 36.23B
25.32x2.8x12.1x-.--% 34.72B
27.42x8.04x20.17x0.41% 27.89B
34.31x5.61x25.58x-.--% 16.79B
22.5x1.95x8.49x1.18% 13.12B
23.43x1.87x11.34x-.--% 12.7B
Average 21.13x 44.57x 11.40x 0.33% 25.4B
Weighted average by Cap. 22.51x 66.40x 12.08x 0.33%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. ATH Stock
  4. Valuation Alterity Therapeutics Limited